Guru Fundamental Report for TMO

Validea's analysis of Thermo Fisher Scientific (TMO) against Pim van Vliet's Multi-Factor Investor model, which prioritizes low volatility, strong momentum, and high net payout yields, yielded a 62% rating. This score falls below the 80% threshold for strategic interest, indicating TMO, a large-cap medical equipment stock, does not strongly align with this conservative factor-based approach despite passing market cap and low volatility criteria, due to neutral momentum and net payout yield scores.

Analysis

Thermo Fisher Scientific Inc. (TMO) was evaluated against Validea's Multi-Factor Investor model, which is based on Pim van Vliet's strategy targeting low volatility, strong momentum, and high net payout yields. TMO, a large-cap stock in the Medical Equipment & Supplies industry, received a score of 62%, falling short of the 80% threshold that indicates strategic interest from the model. While the company successfully passed the criteria for market capitalization and low volatility (standard deviation), its performance was categorized as 'NEUTRAL' on both 'Twelve Minus One Momentum' and 'Net Payout Yield'. Consequently, despite its low-risk characteristics, TMO's overall assessment resulted in a 'FAIL' on its final rank, indicating it does not currently align with the specific combination of factors prioritized by this conservative investment strategy.

Key Decisions for Investors

• Investors following conservative, multi-factor strategies similar to Pim van Vliet's should note that TMO currently fails to meet the criteria for strong momentum and high net payout yield, making it an unsuitable candidate for this specific approach.
• While the stock's low volatility profile is a positive attribute for risk-averse investors, its neutral momentum and yield signals suggest it may underperform peers on those specific factors.
• Traders or investors focused primarily on momentum or shareholder yield should consider that TMO does not exhibit strong signals in these areas according to this quantitative screen, warranting caution or a search for alternative opportunities.